quinapril has been researched along with Alloxan Diabetes in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 9 (64.29) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, L; Kökény, G; Mózes, MM; Révész, C; Rosivall, L; Szénási, G; Vörös, P | 1 |
| Bierhaus, A; Cooper, ME; Jandeleit-Dahm, KA; Li, J; Samijono, D; Thomas, MC; Watson, AM | 1 |
| Aktas, C; Cevat, A; Dogutan, H; Kanter, M; Mehmet, K; Omer, Y; Saniye, S; Sedat, U; Sen, S; Ustundag, S; Yalcin, O | 1 |
| Emmett, T; Kargacin, G; Nygren, A; Schmidt, R; Shimoni, Y | 1 |
| Allen, TJ; Brasacchio, D; Calkin, AC; Cooper, ME; Jandeleit-Dahm, KJ; Koitka, A; Li, J; Rajan, SN; Sheehy, K; Soro-Paavonen, A; Thomas, MC; Watson, AM | 1 |
| Bierhaus, A; Cooper, ME; Gray, SP; Jandeleit-Dahm, KA; Jiaze, L; Pickering, R; Soro-Paavonen, A; Thomas, MC; Tikellis, C; Tsorotes, D; Watson, AM; Wong, B | 1 |
| Fujita, T; Goto, A; Onozato, ML; Tojo, A | 1 |
| Liu, XF; Shimoni, Y | 3 |
| Aoki, M; Higaki, J; Komai, N; Matsumoto, K; Moriguchi, A; Morishita, R; Nakamura, T; Ogihara, T; Tomita, N | 1 |
| Casarini, DE; Ebihara, F; Fonseca, FA; Ihara, SS; Izar, MC; Pinto, LE; Pomaro, DR; Santos, AO; Ueda, I | 1 |
| Barthelmebs, M; Grima, M; Imbs, JL; Jund, A; Petitjean, P; Stephan, D; Vloemans, M | 1 |
| Shimoni, Y | 1 |
14 other study(ies) available for quinapril and Alloxan Diabetes
| Article | Year |
|---|---|
The Effect of Combined Treatment with the (Pro)Renin Receptor Blocker HRP and Quinapril in Type 1 Diabetic Rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Interactions; Drug Therapy, Combination; Kidney; Male; MAP Kinase Signaling System; Quinapril; Rats; Rats, Sprague-Dawley; Renin; Tetrahydroisoquinolines | 2017 |
Quinapril treatment abolishes diabetes-associated atherosclerosis in RAGE/apolipoprotein E double knockout mice.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Diabetes Mellitus, Experimental; Male; Mice, Knockout; Plaque, Atherosclerotic; Quinapril; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Renin-Angiotensin System; Tetrahydroisoquinolines | 2014 |
Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on streptozotocin-induced diabetic nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Female; Immunohistochemistry; Irbesartan; Kidney; Kidney Function Tests; Quinapril; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Tetrazoles; Transforming Growth Factor beta1 | 2008 |
Sex-dependent impairment of cardiac action potential conduction in type 1 diabetic rats.
Topics: Action Potentials; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Connexin 43; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Female; Gap Junctions; Heart Conduction System; Heptanol; Male; Ovariectomy; Quinapril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sex Factors; Tetrahydroisoquinolines; Time Factors | 2009 |
Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apolipoproteins E; Atherosclerosis; Diabetes Mellitus, Experimental; Immunohistochemistry; Male; Mice; Mice, Knockout; Peptidyl-Dipeptidase A; Quinapril; Reverse Transcriptase Polymerase Chain Reaction; Tetrahydroisoquinolines | 2011 |
Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice.
Topics: Albuminuria; Animals; Apolipoproteins E; Diabetes Mellitus, Experimental; Fibrosis; Glomerular Mesangium; Glomerulonephritis; Glycation End Products, Advanced; Male; Mice; Mice, Knockout; Nephritis; Oxidative Stress; Quinapril; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Tetrahydroisoquinolines; Thiazoles | 2012 |
Effect of combination therapy with dipyridamole and quinapril in diabetic nephropathy.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blotting, Western; Creatinine; Cyclic GMP; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dipyridamole; Drug Therapy, Combination; Female; Immunohistochemistry; Isoquinolines; Kidney; Lipid Peroxides; NADH, NADPH Oxidoreductases; NADPH Oxidases; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Phosphodiesterase Inhibitors; Phosphoproteins; Quinapril; Random Allocation; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines | 2003 |
Role of PKC in autocrine regulation of rat ventricular K+ currents by angiotensin and endothelin.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Blotting, Western; Diabetes Mellitus, Experimental; Diglycerides; Electric Conductivity; Endothelin Receptor Antagonists; Endothelins; Enzyme Activation; Enzyme Inhibitors; Heart; Heart Ventricles; Homeostasis; Hypothyroidism; Isoquinolines; Male; Oligopeptides; Potassium Channels; Potassium Channels, Voltage-Gated; Protein Kinase C; Protein Kinase C-epsilon; Quinapril; Rats; Rats, Sprague-Dawley; Saralasin; Shal Potassium Channels; Tetrahydroisoquinolines; Thyroidectomy | 2003 |
Improvement of endothelial dysfunction by angiotensin II blockade accompanied by induction of vascular hepatocyte growth factor system in diabetic spontaneously hypertensive rats.
Topics: Acetylcholine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Endothelium, Vascular; Hepatocyte Growth Factor; Immunohistochemistry; Isoquinolines; Male; Muscle, Smooth; Proto-Oncogene Proteins c-met; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrahydroisoquinolines | 2003 |
Sex differences in the modulation of K+ currents in diabetic rat cardiac myocytes.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Diabetes Mellitus, Experimental; Electric Stimulation; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Female; In Vitro Techniques; Male; Membrane Potentials; Myocytes, Cardiac; Ovariectomy; Patch-Clamp Techniques; Potassium Channels; Quinapril; Rats; Rats, Sprague-Dawley; Sex Characteristics; Tetrahydroisoquinolines | 2003 |
Gender differences in ANG II levels and action on multiple K+ current modulation pathways in diabetic rats.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Action Potentials; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Electric Conductivity; Enzyme Inhibitors; Female; Genistein; Indoles; Male; Maleimides; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels; Protein Kinase C; Protein-Tyrosine Kinases; Quinapril; Rats; Rats, Sprague-Dawley; Sex Characteristics; Signal Transduction; Tetrahydroisoquinolines; Thionucleotides | 2004 |
High glucose levels abolish antiatherosclerotic benefits of ACE inhibition in alloxan-induced diabetes in rabbits.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Blood Glucose; Diabetes Mellitus, Experimental; Hypercholesterolemia; Male; Quinapril; Rabbits; Tetrahydroisoquinolines | 2005 |
Short-term effects of quinapril and nifedipine on early renal changes in streptozotocin-induced diabetes in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Body Weight; Carbon Dioxide; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Eating; Isoquinolines; Kidney; Male; Nifedipine; Oxygen; Partial Pressure; Peptidyl-Dipeptidase A; Quinapril; Rats; Rats, Wistar; Renal Circulation; Tetrahydroisoquinolines | 1994 |
Inhibition of the formation or action of angiotensin II reverses attenuated K+ currents in type 1 and type 2 diabetes.
Topics: Action Potentials; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Electric Conductivity; Isoquinolines; Mutation; Potassium Channels; Quinapril; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Angiotensin, Type 2; Receptors, Cell Surface; Receptors, Leptin; Saralasin; Tetrahydroisoquinolines; Tetrazoles; Valine; Valsartan | 2001 |